These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9403351)

  • 21. Natural killer cell activity and response to phytohaemagglutinin compared with the histological diagnosis of patients with transitional cell carcinoma of the bladder.
    Britten V; Rees RC; Clegg A; Smith GT; Potter CW; Fox M; Williams JL
    Br J Urol; 1982 Jun; 54(3):261-6. PubMed ID: 7104588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
    Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
    BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence.
    Giannopoulos A; Constantinides C; Fokaeas E; Stravodimos C; Giannopoulou M; Kyroudi A; Gounaris A
    Clin Cancer Res; 2003 Nov; 9(15):5550-8. PubMed ID: 14654535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
    Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies.
    de Harven E; Fradet Y; Connolly JG; Hanna W; He S; Wang Y; Choi BC; McGroarty R; Bootsma G; Tilups A
    Cancer Res; 1992 Jun; 52(11):3131-7. PubMed ID: 1591726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of interferon alfa-2c on the kinetics of spontaneous cell-mediated cytotoxicity in urothelial carcinoma in vivo and in vitro.
    Grups JW; Stock T; Frohmüller HG
    Urol Res; 1988; 16(6):399-402. PubMed ID: 3232274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ultrastructure of the noninvolved urothelium of tumor-bearing patients before and after interferon treatment.
    Stravoravdi P; Belivanis J; Dimopoulos T; Hatzigiannis J; Polyzonis M
    J Interferon Res; 1992 Dec; 12(6):397-402. PubMed ID: 1289406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.
    O'Donnell MA; Luo Y; Hunter SE; Chen X; Hayes LL; Clinton SK
    J Urol; 2004 Mar; 171(3):1336-42. PubMed ID: 14767344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of patients with transitional cell carcinoma of the urinary bladder with intravesical poly I: poly C effects on natural killer function.
    Moroz C; Kupfer B; Lindner A; Many M
    Cancer Immunol Immunother; 1985; 20(3):236-40. PubMed ID: 2415237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines in superficial bladder cancer.
    da Silva FC
    Acta Urol Belg; 1996 May; 64(2):29-30. PubMed ID: 8701804
    [No Abstract]   [Full Text] [Related]  

  • 33. Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder.
    Moltó LM; Carballido JA; Manzano L; Olivier C; Lapuerta M; Alvarez-Mon M
    Int J Immunopharmacol; 1993 Apr; 15(3):335-41. PubMed ID: 8505146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological findings in patients with superficial bladder cancer during human alpha-2-interferon treatment.
    Grups JW; Frohmüller HG; Ackermann R
    Urol Int; 1985; 40(6):301-6. PubMed ID: 4090102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phagocytic and natural killer cytotoxic responses of murine transitional cell carcinoma to postsurgical immunochemotherapy.
    Woolley JL; Lau BH; Ruckle HC; Torrey RR
    J Urol; 1988 Sep; 140(3):660-3. PubMed ID: 3411696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated.
    Reyes E; Carballido J; Prieto A; Molto L; Manzano L; Alvarez-Mon M
    Eur Urol; 1997; 31(4):472-7. PubMed ID: 9187910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transitional cell carcinoma of the renal pelvis with choriocarcinomatous differentiation. Immunohistochemical and immunoelectron microscopic assessment of human chorionic gonadotropin production by transitional cell carcinoma of the urinary bladder.
    Grammatico D; Grignon DJ; Eberwein P; Shepherd RR; Hearn SA; Walton JC
    Cancer; 1993 Mar; 71(5):1835-41. PubMed ID: 8448745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-antigen in normal and neoplastic urothelium.
    Limas C; Lange P
    Cancer; 1986 Sep; 58(6):1236-45. PubMed ID: 3742450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacillus Calmette-Guérin-treated superficial bladder cancer: correlation of morphology with immunophenotyping.
    Leong AS; Wannakrairot P; Jose J; Milios J
    J Pathol; 1990 Sep; 162(1):35-41. PubMed ID: 2231190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.